<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/66A1D773-B5EC-42B7-96C9-5F57EFFF97C3"><gtr:id>66A1D773-B5EC-42B7-96C9-5F57EFFF97C3</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Paton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EDAB4FFF-7507-4037-9884-BDFCB07D19B7"><gtr:id>EDAB4FFF-7507-4037-9884-BDFCB07D19B7</gtr:id><gtr:firstName>Satya</gtr:firstName><gtr:surname>Parida</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5DC8742C-F283-44E9-9393-25DE98BDE551"><gtr:id>5DC8742C-F283-44E9-9393-25DE98BDE551</gtr:id><gtr:firstName>Geraldine</gtr:firstName><gtr:surname>Taylor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FI%2F00001416"><gtr:id>E4656B08-B451-45FF-B5EA-9302D1234485</gtr:id><gtr:title>Development, enhancement and complementation of animal-sparing foot and mouth disease vaccine based control strategies for free and endemic regions</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/I/00001416</gtr:grantReference><gtr:abstractText>Foot-and-mouth disease (FMD) is one of the world?s most infectious diseases of livestock and continues to pose a significant threat to endemic and free regions alike. The impact of FMD on society and international trade is high, thereby demanding stringent prevention, surveillance and control plans taken up in crisis preparedness plans. On the other hand, there is a global increased demand for animal welfare and ethical considerations necessitating a decreased reliance on eradication of animals to control FMD virus (FMDV) spread, and on the use of animals for the regulatory testing of veterinary products. The project seeks to balance these apparently contrasting viewpoints by addressing specific gaps in our knowledge on all aspects of FMD control to enable implementation of enhanced animal-sparing vaccine-based control strategies tailored to the needs of free and endemic settings. Consequently, four main objectives have been identified, including (i) the improvement of the quality of existing FMD vaccines and diagnostics, (ii) the refinement and replacement of in vivo FMD vaccine quality tests, (iii) the development of new generation FMD vaccines and diagnostics by applying cutting edge technologies, and (iv) the enhancement of our knowledge on FMDV spread and transmission following the use of high-potency monovalent or multivalent vaccines. The role of wildlife (buffalo, gazelles and wild boar) in FMDV maintenance and transmission will also be investigated. The project consists of seven different, yet interlinked, work packages (WP) each addressing one of the items listed in the Work Programme topic KBBE-2008-1-3-02, and led by renowned WP leaders with years of relevant experience in the field of FMD. As such, significant progress towards the objectives of the Community's Animal Health Strategy (2007-2013), the European Technology Platform for Global Animal Health, and the Global Roadmap for improving the Tools to Control FMD in Endemic Settings will be achieved.</gtr:abstractText><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>184617</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8F4016C2-0818-4F42-978D-2E93743B57F9</gtr:id><gtr:title>Transmission of foot-and-mouth disease virus from experimentally infected Indian buffalo (Bubalus bubalis) to in-contact na&amp;iuml;ve and vaccinated Indian buffalo and cattle.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aecd178bf491ed1d1fac225e96bbe39"><gtr:id>1aecd178bf491ed1d1fac225e96bbe39</gtr:id><gtr:otherNames>Madhanmohan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56e7daae3731e2.85113579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B28EEDB8-BB19-4F8B-BC62-24C46EBBD487</gtr:id><gtr:title>The use of serosurveys following emergency vaccination, to recover the status of &amp;quot;foot-and-mouth disease free where vaccination is not practised&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05cccd95d22a663362597b67f3de1213"><gtr:id>05cccd95d22a663362597b67f3de1213</gtr:id><gtr:otherNames>Paton DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56e7daade08782.81760437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CE9886-C370-4A36-8C54-4C2F0F9CC84A</gtr:id><gtr:title>Reducing animal experimentation in foot-and-mouth disease vaccine potency tests.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84266c39519fdec9b263e1ab8c983276"><gtr:id>84266c39519fdec9b263e1ab8c983276</gtr:id><gtr:otherNames>Reeve R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56e7daae5c4548.74591926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02B4C016-0D29-4EFD-99F0-7248A26BBF79</gtr:id><gtr:title>CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16bd597fd18bbbf01db31734b1fdb5d1"><gtr:id>16bd597fd18bbbf01db31734b1fdb5d1</gtr:id><gtr:otherNames>Carr BV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_5435b225b228128f1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15B3F2FF-7831-43AC-B7B5-8090D2C616ED</gtr:id><gtr:title>Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d495066860a08816b32799bb097075"><gtr:id>27d495066860a08816b32799bb097075</gtr:id><gtr:otherNames>Mahapatra M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56e7daae1095d2.20562850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99709025-09DB-4EB8-ADB9-42CE392DA24A</gtr:id><gtr:title>Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aecd178bf491ed1d1fac225e96bbe39"><gtr:id>1aecd178bf491ed1d1fac225e96bbe39</gtr:id><gtr:otherNames>Madhanmohan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>pm_5435b225b228a3269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A713D138-9A7B-4D52-8150-5CF6DFC6C1D0</gtr:id><gtr:title>Validation of a recombinant integrin av?6/monoclonal antibody based antigen ELISA for the diagnosis of foot-and-mouth disease.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/684b255df533cd008192c2a93dc32b85"><gtr:id>684b255df533cd008192c2a93dc32b85</gtr:id><gtr:otherNames>Ferris NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>56e7daae85e890.01185325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9EE765C-A441-4D24-B5B4-347B13832925</gtr:id><gtr:title>Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f7503be0f11fdfb86f4ac5a63961e8e"><gtr:id>8f7503be0f11fdfb86f4ac5a63961e8e</gtr:id><gtr:otherNames>Nagendrakumar SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>doi_53d00e00ece1cb5b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0DE8892-04CE-446D-824F-28670200A904</gtr:id><gtr:title>Interferon-? induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/506742cb5e64e379e0d4ca2d134c00b4"><gtr:id>506742cb5e64e379e0d4ca2d134c00b4</gtr:id><gtr:otherNames>Oh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_5435b225b2294acea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5F6CEC8-E313-4248-A1B8-CB4C90E91579</gtr:id><gtr:title>Diagnosis of foot-and-mouth disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05cccd95d22a663362597b67f3de1213"><gtr:id>05cccd95d22a663362597b67f3de1213</gtr:id><gtr:otherNames>Paton DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56e7dccc223014.11414195</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/I/00001416</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>